VERSION 1 -REVIEW
negative predictive values (and true/false positives and negatives) of the initial screening for diagnosis of MCI. This represents the "best case" scenario for assessments that could be performed by a patient's primary care provider relative to the gold standard of multidisciplinary specialty care. This is a (or the) key implication of the study's findings for clinical practice. Ideally, the authors would analyze the diagnostic efficiency for the questionnaire data versus the structured interview and MMSE results, i.e., are questionnaires as efficient as the more intensive measurements.
The authors offer two explanations of why patients who were false screening positives might have experienced improved depression and HRQOL. One is that their depression and reduced HRQOL is a result of self-suspected MCI, which was relieved by the negative diagnostic results. However, the authors offer no evidence for this possibility, including evidence from other studies of negative diagnosis improving depression and HRQOL. Similarly, the authors offer no evidence regarding the claim that depression tends to resolve over time in the absence of treatment (which apparently is the case in this study, although the authors never state explicitly that treatment was not provided to patients who were not diagnosed with MCI -the absence of this data being a study limitation). In other words, were screen positive patients without MCI worried about being MCI, such that relieving this concern improved depression and HRQOL? In addition, the authors should review the evidence from other studies that depression is associated with decrements in cognitive functioning. If there is more evidence for this interpretation than the previous interpretation, the authors should comment on the preponderance of evidence for the different interpretations.
Ultimately, the authors are responsible for articulating arguments for/against the two interpretations they advance for their findings regarding the false screening positives. Failure to do so makes this study a research note at best, with others left with the task of making sense of what this study tells us. And this study would only inform us about the screening efficacy for MCI of questionnaires versus standardized interviews and MMSE.
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GENERAL COMMENTS
The study looks at an important and clinically relevant topic of cognitive impairment in patients with diabetes and its association with depression and health related QoL. It is a well designed study that has used a two step methodology to screen and diagnose cognitive impairment, following which patients are followed up longitudinally by their GP and the Researchers have looked at the trajectory of depression and QoL over 2 years with a fairly high retention rate.
The discussion section needs to be significantly strengthened and the main findings of high levels of depressive symptoms in patients with cognitive impairment as well as the trajectory of depressive symptom syndrome in the 3 groups needs to be further elaborated and discussed. For example: what role did the patients' GP play in being able to stabilise the depressive symptoms in the 1st group or improve the symptoms in the 2nd group. So I am entitrely convinced that the change in depressive symptoms and QoL was solely due to the screening and there could have been other factors that contributed to others.
The Writers are not native English speakers so it would be good to get it proof-read to correct the grammatical errors.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1, Mark Peyrot
The methodology of this paper is sound. There are meaningful results regarding each of the three groups studied. However, the authors do little to interpret the results in order to transform them into findings.
Reply authors
Thank you for this comment. We agree with the reviewer that the discussion part of the paper could be improved. This would make it easier to translate our results into implications for clinical practice. We considerablyadjusted the discussion part based on all reviewers' comments.
The Discussion proceeds from a summary of results into strengths and limitations of the study. The latter should come immediately before the implications for practice and after the interpretation of the findings. Most of the "implications for practice" are actually the interpretations of results, i.e., that screening does not increase depression or reduce quality of life, and that it may be associated with improvement in depression and HRQOL. The authors offer two interpretations of the improvement in wellbeing of patients screened negative for cognitive impairment, but they do not evaluate the two possible interpretations. Moreover, they do not fully consider the clinical/practice implications of their results.
We now changed the order of the paragraphs in de discussion section into: 1) Summary 2)
Interpretation of the results and comparison with existing literature 3)
Strengths and limitations 4) Implications for practice 5) Conclusions
We also adjusted the paragraph "implications for clinical practice", and moved the paragraphs about interpretation of the results to the corresponding paragraph.
The authors describe the screening process, but some details are omitted, specifically whether the screening physician was blinded to the scores on depression and HRQOL questionnaires. If not, this could lead to bias in the screening process, i.e., they could influence the results of the structured interview and MMSE so that depressed patients were more likely to be screened as positive.
The screening physician was indeed blinded to the scores on the depression and HRQOL questionnaires.
We adjusted the following sentence at page 5 to address this:
Afterwards, the research physician, blinded for the HRQOL and depression scores and for the TYM-and SAGE-scores, performed an evaluation with a structured interview and the Mini-Mental State Examination (MMSE).
The authors also do not state whether the multidisciplinary team was blinded to the specific results of the screening measures. This is important as it bears on the issue of how depressed patients were more likely to be screened positive in spite of not having MCI.
We did not find previous studies assessing depressive symptoms or HRQOL after screening for cognitive impairment. The negative diagnostic memory clinic results could have been a reason for this, but this is speculation and not based on evidence. To make this more clear we added the following sentence:
"However, we did not find any evidence in the literature that depressive symptoms or HRQOL could be improved by reassuring diagnostic results."
Similarly, the authors offer no evidence regarding the claim that depression tends to resolve over time in the absence of treatment.
We rephrased this section to make it more clear:
" Another explanation for these findings could be that the depressive symptoms of (a part of) these patients mimicked the symptoms of cognitive impairment during screening. This may have resulted in a high number of depressive symptoms in the group of screen positive participants without cognitive impairment at baseline. Either as a result of the natural course or as a result of therapy depressive symptoms may have disappeared during follow-up, with a corresponding improvement of HRQOL scores."
(Which apparently is the case in this study, although the authors never state explicitly that treatment was not provided to patients who were not diagnosed with MCI -the absence of this data being a study limitation.)
The results of the visit to the memory clinic and treatment advice was sent to the participants' own general practitioner who discussed the results with the participant. The general practitioner and the participant decidedtogether what actions had to be taken. Further support by the memory clinic was available if this was considered desirable by the general practitioner and the participant. Information about treatment of depressive symptoms by the GP was not available. We now added the following sentences to clarify this:
In the method section: "The GP and the participant decided together what actions were necessary. When desirable, further support by the memory clinic was available."
In the strengths and limitations section: "All memory clinic results and treatment advice were sent to the patients' own GP. The GP was asked to discuss the results with the patient; however, we do not know which actions were actually taken and whether these influenced depressive symptoms and HRQOL. "
In other words, were screen positive patients without MCI worried about being MCI, such that relieving this concern improved depression and HRQOL? In addition, the authors should review the evidence from other studies that depression is associated with decrements in cognitive functioning. If there is more evidence for this interpretation than the previous interpretation, the authors should comment on the preponderance of evidence for the different interpretations.
There are several studies, including reviews, that indicate that depression and cognitive impairment are associated, both in patients with and in those without diabetes. The relationship, however, between depression and cognitive impairment is complex and still not completely understood. We previously reported on the association between cognitive impairment, HRQOL and depressive symptoms in patients with type 2 diabetes (Koekkoek P et al. Journal of Diabetes and its Complications, 2015) and focused on changes in depressive symptoms and HRQOL after screening in the current paper. However, we agree with the reviewer that some more background information about the association between depression, HRQOL and cognitive impairment would improve the readability of this paper. We therefore added a separate paragraph to the discussion section:
